Structural Brain Volumetry Changes in Eating Disorders.
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age13-60
SponsorAssiut University
About this trial
The goal of this observational study is to investigate the relationship between structural brain changes and psychiatric comorbidities in individuals diagnosed with eating disorders (EDs). The main question it aims to answer is:
How are structural brain volumetric changes associated with psychiatric comorbidities in patients with eating disorders?
Participants with a clinical diagnosis of an eating disorder will undergo brain MRI scans for volumetric analysis and structured psychiatric assessments to identify comorbid conditions. Data will be collected cross-sectionally from patients receiving routine clinical care, with the aim of identifying neurobiological and psychiatric patterns that could inform targeted treatment and prevention strategies.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age above 13 years.
DSM-5 diagnosis of an eating disorder (AN, BN, BED) confirmed by structured interview.
Disqualifiers
Neurological or any previous psychiatric diagnosis.
IQ less than 70.
MRI contraindication (metal implants, pacemaker, severe claustrophobia).
Trial population
Study Setting: in Assuit university hospitals, Neuropsychiatry hospital Outpatient Clinic Study subjects: will include three groups of patients with eating disorders: Anorexia nervosa patients, Bulimia Nervosa patients, Binge-eating patients, and healthy control group they will be age and sex matched.
Trial design
Design model
Case-control
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
80 Participants
are grouped into 4 trial groupsGroup A: Anorexia Nervosa Patients
Group B: Bulimia Nervosa Patients
Group C: Binge-Eating Disorder
Group D: control group
Trial outcomes
Primary outcomes
1
To assess structural changes of brain volumetry in patients with eating disorders and compare with healthy controls.
Time frame
from enrollment till 18 monthsSecondary outcomes
1
Highlight the extent of psychological disorders in such patients.
Time frame
From enrollment till 18 monthsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: